ipatasertib Clinical Research Trials

Found 7 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For all genders
Neurology
Recruiting

A Trial of Ipatasertib in Combination With Atezolizumab

This is a single centre, proof-of-concept phase I trial of atezolizumab in combination with ipatasertib. There are two parts to this study, the dose escalation phase (Part A) and the dose

measurable disease

serum bilirubin

neutrophil count

cancer

platelet count

15 views
23 Jun, 2021
1 location

Multi-country trial
Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Family Medicine
Recruiting

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer

This is a multicenter, open-label, non-comparative, three-arm, phase IIa trial of Ipatasertib (GDC-0068) in combination with non-taxane chemotherapy agents for taxane-pretreated unresectable

0 views
15 May, 2021
17 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For all genders
Recruiting

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients

This is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with

bone metastases

trastuzumab

her2/neu-positive breast cancer

aptt

platelet count

0 views
25 Jan, 2021
6 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For all genders
Recruiting

Ipatasertib in Combination With Carboplatin Carboplatin/Paclitaxel or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer

This phase I trial studies best dose of ipatasertib and how well it works with carboplatin with or without paclitaxel in treating patients with triple negative breast cancer that has spread to

4 views
25 Jan, 2021
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Family Medicine
Recruiting

AKT Inhibitor Ipatasertib With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

This research is looking to find out if the combination of Ipatasertib with Aromatase inhibitor or Fulvestrant can be an effective treatment for breast cancer.

estradiol

aromatase inhibitor

estrogen

measurable disease

erbb2

6 views
25 Jan, 2021

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For all genders
Family Medicine
Recruiting

Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

The purpose of this study is to find out whether a new drug, Ipatasertib, can slow the growth of advanced breast cancer when added to standard therapy (Fulvestrant).

mammogram

advanced breast cancer

estrogen receptor